Find out all about your favorite commercial!

Advertisers

Advertisers of the ENTYVIO TV Spot, 'When Your Symptoms Say: Not Today'

ENTYVIO TV commercial - When Your Symptoms Say: Not Today
ENTYVIO

ENTYVIO is a trademark of Millennium Pharmaceuticals, Inc., registered with the U.S. Patent and Trademark Office and is used under license by Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO is a medicati...

What the ENTYVIO TV commercial - When Your Symptoms Say: Not Today is about.

ENTYVIO TV commercial - When Your Symptoms Say: Not Today

Title: ENTYVIO TV Spot: When Your Symptoms Say, "Not Today"

Life is full of moments. Moments you don't want your chronic inflammatory bowel disease symptoms interfering with.

But when your symptoms say, "Not today," it's time to fight back.

That's where ENTYVIO comes in.

ENTYVIO, a breakthrough treatment for adults with moderate to severe ulcerative colitis or Crohn's disease, offers the power to help control your symptoms.

So when your symptoms try to bring you down, remember ENTYVIO is here to lift you up.

With ENTYVIO, you can get back to the moments that matter most.

ENTYVIO is a prescription medicine. It may cause serious side effects. Talk to your doctor about the benefits and risks. It's time to take control of your chronic inflammatory bowel disease symptoms. Say, "Not today."

[Scene: The screen fades to black, leaving only the ENTYVIO logo and tagline.]

ENTYVIO: When Your Symptoms Say, "Not Today."

[Upbeat music fades out.]

[Disclaimer: Consult your doctor or healthcare professional before starting or changing any medication.]

Note: This description is purely fictional and does not reflect any specific ENTYVIO TV spot. The purpose is to create an engaging and imaginative representation of the commercial based on the given context.

ENTYVIO TV commercial - When Your Symptoms Say: Not Today produced for ENTYVIO was first shown on television on June 29, 2020.

Frequently Asked Questions about entyvio tv spot, 'when your symptoms say: not today'

In conclusion, the actress in the Entyvio commercial is the talented Lorraine Toussaint. With her exceptional acting skills and ability to bring characters to life, Toussaint has captivated audiences in various films, television shows, and stage productions.

How quickly does Entyvio work? In studies of Entyvio, most people had fewer symptoms of ulcerative colitis or Crohn's disease after 6 weeks of treatment.

Entyvio has an average rating of 5.8 out of 10 from a total of 135 reviews on Drugs.com. 44% of reviewers reported a positive experience, while 32% reported a negative experience.

Entyvio is meant to be used as a long-term treatment. If you and your doctor determine that Entyvio is safe and effective for you, you'll likely take it long term. If Entyvio doesn't reduce your CD or UC symptoms after 14 weeks of treatment, your doctor may have you stop taking the drug.

Entyvio, from Takeda Pharmaceuticals, was first approved by the U.S. Food and Drug Administration (FDA) on May 20, 2014.

Women are more likely to develop Crohn's disease than men, but more men develop ulcerative colitis than women. Even though the average age of developing IBD is between 15 and 35, more men are diagnosed with ulcerative colitis in their 50s and 60s than women of the same age.

At Week 52, in the anti‑TNFα naïve subpopulation, clinical remission rates were 52% for those who received Entyvio vs. 27% for those who received placebo. In the anti‑TNFα failure subpopulation, clinical remission rates were 28% for those who received Entyvio vs. 13% for those who received placebo.

Signs Your Ulcerative Colitis Treatment Isn't Working Dr. Philpott says that an increase in your bowel movements, trouble or pain passing stool, weight loss, fevers, blood in stool, and fatigue could be signs that it's time to discuss a change with your doctor.

People who take Entyvio have an increased risk of infection, such as the common cold or flu. More serious infections may also occur. These might include tuberculosis or an infection in the brain called progressive multifocal leukoencephalopathy (see below).

ENTYVIO made remission real for many people with moderate to severe ulcerative colitis (UC) In two clinical trials, ENTYVIO delivered results for adults with moderate to severe ulcerative colitis when other medicines had not worked well enough or could not be tolerated.

Entyvio is a biologic drug, which means that it's made from living cells. If this medication works for you, your doctor will likely recommend that you use it long term.

Kynteles which is sold globally as Entyvio in more than 60 countries, generated sales of $3.2 billion in FY20. Takeda India, part of the Japanese pharma major Takeda Pharmaceutical Company announced the launch of its blockbuster biologic drug Vedolizumab in India as part of its Gastrointestinal (GI) portfolio.

Videos

Watch ENTYVIO TV Commercial, 'When Your Symptoms Say: Not Today'

We analyzed TV commercials placed on popular platforms and found the most relevant videos for you:

Products

Products Advertised

ENTYVIO
TV commercials

Similar commercials

ENTYVIO TV Spot, 'Made for You'
460 January 6, 2022
Toys R Us Holiday Catalog TV Spot, 'Exercise'
ENTYVIO TV Spot, 'Your Plan Can Change in Minutes: Chef'
Lands' End No Iron Dress Shirt TV Spot, 'Made to Work'
ENTYVIO TV Spot, 'Your Plans Can Change in Minutes'
Carhartt TV Spot, 'Mentor' Song by Cereus Bright
Cabela's Pre-Black Friday Sale TV Spot, 'It's That Season Again'
Carhartt TV Spot, 'The Carhartt Way of Life'
Carhartt TV Spot, 'Luck Doesn't Defend a Title' Featuring Jordan Lee
Eddie Bauer TV Spot, 'Life Lessons'
Carhartt TV Spot, 'Outfish Them All' Song by The Siege
Tac Visor TV Spot, 'Light-Filtering Technology'